The FDA pulled Evusheld from the market because it is not effective against more than 90% of the Covid subvariants that are currently circulating in the U.S. People with compromised immune systems ...

By Laura Baisas | Published Jan 27, 2023 9:00 AM On Thursday, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee unanimously voted to support a ...

According to the new rules, which won't go into effect until the FDA finalizes them in the coming months, MSM and their partners will be able to donate blood without any waiting period.

Evusheld doesn't neutralize against several omicron subvariants, the FDA says. The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a COVID-19 ...

The Food and Drug Administration (FDA) has lifted a decades-long ban on sexually active gay and bisexual men from donating blood, overruling a restriction dating back to the 1980s AIDS crisis.

"[I]t is not apparent how CBD products could meet safety standards for dietary supplements or food additives," FDA Deputy Commissioner Dr. Janet Woodcock said in a statement. She added, "For ...

The FDA is looking for the experts' take on that recommendation, as well as providing twice-annual boosters for people who are immune-compromised or over a certain age to increase their chances ...

The FDA on Friday proposed new guidelines that ... children’s health The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market FDA ...

26, 2023 - A panel of advisers to the FDA unanimously supported an effort ... “That is a real challenge,” said McInness, a former deputy director of the National Center for Advancing ...

OH, BOY. YEAH. OH, RIGHT. WE’RE IN SEASON WHEN IT COMES TO ICE FISHING. AND GREG, THIS IS GREAT TIMING CAUSE IT’S BEEN COLD HERE. NOW, RIGHT? TIMING FOR THE GREAT OUTDOOR SEGMENT HERE AS WE ...

These findings could improve our understanding of changes in the atmosphere–ice–ocean system and the balance of sea ice in the Arctic. The new study was published in November in the European ...

The FDA had limited Evusheld’s use earlier this month for the same reason and the agency’s Thursday announcement sent U.S. shares of London-based AstraZeneca down 1.31% to $65.75.